-

Schrödinger to Host First Quarter 2020 Financial Results Conference Call and Webcast

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced that it will host a conference call and webcast on Wednesday, May 13, 2020 at 8:30 a.m. ET to discuss first quarter 2020 financial results and provide a general business update.

Interested participants and investors may access the conference call by dialing (833) 727-9520 (domestic) or +1 (830) 213-7697 (international) and refer to conference ID 2783269. The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. The archived webcast will be available on the Company's website following the event.

About Schrödinger

Schrödinger’s industry-leading computational platform to accelerate drug discovery and materials design is deployed by leading biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger is also applying its computational platform to a diverse and extensive pipeline of drug discovery programs in collaboration with pharmaceutical companies and has co-founded leading biotech companies. In addition, Schrödinger is using its platform to advance a pipeline of internal, wholly-owned drug discovery programs.

Contacts

Media Contact:
Stephanie Simon
Ten Bridge Communications
stephanie@tenbridgecommunications.com
617-581-9333

Investor Contact:
Christina Tartaglia
Stern IR, Inc.
christina.tartaglia@sternir.com
212-362-1200

Schrödinger

NASDAQ:SDGR

Release Summary
Schrödinger (Nasdaq: SDGR) will host a conference call and webcast on May 13, 2020 to discuss first quarter 2020 financial results.
Release Versions

Contacts

Media Contact:
Stephanie Simon
Ten Bridge Communications
stephanie@tenbridgecommunications.com
617-581-9333

Investor Contact:
Christina Tartaglia
Stern IR, Inc.
christina.tartaglia@sternir.com
212-362-1200

More News From Schrödinger

Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will provide a corporate overview during the H.C. Wainwright Global Life Sciences Conference....

Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it has expanded its collaboration with Google Cloud....

Schrödinger to Present at the SVB Leerink Partners 10th Annual Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will provide a corporate overview at the SVB Leerink Partners 10th Annual Global Healthcare Conference....
Back to Newsroom